CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) (USD $)	12 Months Ended		56 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011
Research and Development Expense
Stock option expense	$ 66,098	$ 55,249	$ 369,355
Amortization expenses	211,709	197,267	791,463
Technology impairment charge	345,000		345,000
General and Administrative Expense
Stock option expense	316,820	422,107
Stock option and warrant expense			2,581,014
Stock for services			$ 300,000